New brain mechanisms regulating body weight

May 02, 2019

Researchers at University of Gothenburg, Sweden, clarify the link between the molecule interleukine-6 (IL-6) in the brain and obesity. In experiments on rats and mice they show that the molecule does affect the risk of obesity, and also where this effect occurs in the brain.

Interleukine-6 (IL-6) is a well-known pro- inflammatory molecule, and an integral element of body's first line of defense during infection. Intriguingly, the brain may govern and utilize IL-6 differently from the rest of the body.

Researchers led by the laboratory of Karolina Skibicka at the Sahlgrenska Academy,Sweden (Mishra et al Cell Reports, 2019: https://www.ncbi.nlm.nih.gov/pubmed/30865890), asked: what happens to IL-6 levels in the brain following a diet that leads to obesity?

Rats and mice were offered a high-calorie palatable food - a mix of fat and sugar, in addition to their regular low-calorie diet - like many humans, rodents choose to overeat when presented with calorie dense foods.

"What we found was that the rats and mice that became obese, had reduced IL-6, but only in one brain region, called Lateral Parabrachial Nucleus (lPBN)", says Devesh Mishra, postdoctoral fellow leading the study.

"To understand whether this reduction of IL-6 is a good or bad thing for the metabolic health of the rodents, we viro-genetically reduced IL-6 levels very selectively in the lPBN; this led to increased body weight and body fat, even in rodents fed a healthy diet".

Therefore, the researchers conclude that the reduced levels of lPBN IL-6 in obesity are problematic, and likely contribute to metabolic dysfunction and weight gain.

Since body weight is a result of how much we eat i.e. energy intake and how much energy we use i.e. energy expenditure, weight gain can follow dysfunction of either one of these branches of energy balance.

What makes local parabrachial nucleus-produced IL-6 extra important, the study found, is that it affects both branches simultaneously: it decreases food intake and increases energy expenditure, the latter by increasing brown fat activity, so body's energy is utilized for heat generation or fat burning. Hence reduced levels of lPBN IL-6 disrupt the entire energy balance equation.

These findings may be relevant not only for mice but also men, since an earlier study from University of Gothenburg, revealed that blood serum IL-6 levels in obese and overweight men are increased, yet brain IL-6 levels, measured in cerebrospinal fluid, are reduced.

There is one unsolved piece of the puzzle in these new findings - researchers found that the obesity-associated reduction in IL-6 was only present in males. Female rats and mice had normal IL-6 levels. The Sahlgrenska team is now investigating why females are protected from the obesity-associated IL-6-driven dysfunction.

Given that obesity is a major global disorder with 1.9 billion overweight individuals out of which 650 million are obese, new effective anti-obesity treatment are desperately needed to minimize the amount of personal and medical burden on individuals and overall our societies. On the scientific end, we think that IL-6 as a satiety mediating substance with a brain region specificity is an important discovery and can open new directions in the quest for more effective anti-obesity strategies.
-end-
Contact infromation:

Karolina Skibicka, Associate Professor, Research group leader, Sahlgrenska Academy, University of Gothenburg, +46 31 786 3436, karolina.skibicka@neuro.gu.se

Devesh Mishra, researcher, Sahlgrenska Academy, University of Gothenburg, +46 76 176 4191, devesh.mishra@neuro.gu.se

University of Gothenburg

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.